Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
113NH3 PET/CT scan----[1] 84
218F-DOPA PET----[1] 6
318FDG PET/CT scan----[1] 84
468Ga-DOTATATE PET/CT[2] Dotatate,
Dotatate gallium Ga-68		---[1] 84
5[18F] LBT-999 PET----[1] 6
6[18F]-FLT-PET/CT scans----[1] 34
7[18F]DPA-714 PET----[1] 2
8[18F]DPA-714 PET scan----[1] 6
9[18F]FDOPA PET/CT----[1] 6
10[18F]Florbetapir PET imaging----[1] 13
11[18F]FPEB PET imaging----[1] 206
12[68Ga]Ga-PentixaFor PET/CT----[1] 84
13[C11]PK-1195 PET scan----[1] 13
14[Zr-89]Oxine-labeled leukocytes PET/MRI[1] Oxyquinoline[1] D05321 --[1] 13
15DPA-714 PET/MRI----[1] 13
16DPA-714-PET/MRI----[1] 6
17ESR-specific PET scan----[1] 86
18GE180 PET Scan----[1] 6
19PET----[1] 6
20PET with 11C-Flumazenil[1] Flumazenil[1] D00697 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[1] 13
21PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----[1] 85
22PET10----[1] 41
23PET3----[1] 41
24Petrolatum[1] Petrolatum[1] D05331 (Name: Petrolatum)--[1] 158